A new discovery showing how hair growth activated fat tissue growth in the skin below the hair follicle could lead to the development of a cream to dissolve fat.
In particular, the protein that activated hair follicle growth was shown to also inhibit fat production.
The world first research confirmed that changes in the hair growth cycle led to fluctuations in the thickness of the underlying fat layer of the skin – essentially meaning that the skin can regulate fat production.
The research was led by Professor Fiona Watt at King’s College London in collaboration with Professor of Dermatology Rodney Sinclair from the University of Melbourne and Epworth Hospital.
Professor Sinclair said these findings could potentially be used both as a means to replace fat lost in scar tissue or as a localised treatment for obesity.
“The specific chemicals identified in this study could be produced synthetically and used in creams for topical application to the skin to modulate growth of fat beneath the skin.”
“A cream could trim fat specifically where it was applied by ‘pausing’ the production of factors that contribute to fat cell growth.” he said.
The effect of changes in the fat tissue on the synchronised patterns of hair follicle growth has long been established.
“This is the first demonstration that the opposite also holds true in that the skin below the hair follicle can regulate the development of fat,” Professor Sinclair said.
This discovery could also affect future treatment of obesity, male and female pattern baldness and alopecia – male and female baldness – an autoimmune condition that affects one to two per cent of the general population at some stage in their life.
The Latest on: Obesity
[google_news title=”” keyword=”Obesity” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Obesity
- Unveiling the Link: Obesity and Faecal Incontinence Relationshipon May 12, 2024 at 1:00 am
Recent research has investigated whether the link between obesity and faecal incontinence depends on how fat is distributed in the body.
- Gradual weaning off anti-obesity jabs could help avoid weight gain – studyon May 11, 2024 at 3:01 pm
Gradual weaning off anti-obesity jabs could help avoid weight gain – study - Researchers found a lower dose of the drug semaglutide could also be effective for weight loss when combined with lifestyle ...
- Supported Exercise Intervention Helps Black Women With Obesity Shed Weighton May 11, 2024 at 2:14 pm
NEW ORLEANS -- A "culturally sensitive" exercise intervention led to weight loss and other benefits in African-American women with obesity at risk for diabetes, researchers reported.
- Nearly 40% of the cancer cases are due to obesity, finds new studyon May 11, 2024 at 7:26 am
A study linking cancer to obesity highlights the crucial role of BMI, inflammation, and lifestyle factors in cancer development. The researchers identified a link between 32 types of cancer and ...
- The public wants Medicare to cover obesity drugson May 10, 2024 at 6:07 am
Medicare is currently barred from covering drugs for weight losses purposes. But roughly 61% of adults say they think Medicare should cover these medications, including 66% of Democrats and 55% of ...
- India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO sayson May 10, 2024 at 2:52 am
Cipla is open to partnering with U.S. drugmaker Eli Lilly to market its blockbuster obesity treatment drugs in India, the company's CEO said on Friday.
- Why does working a night shift raise the risk for diabetes and obesity? Experts weigh inon May 9, 2024 at 2:29 pm
Working a night shift for even a short time could negatively impact your health and scientists are researching why.
- Gut bacteria identified as potential link between maternal smoking and child obesityon May 9, 2024 at 12:44 pm
It's long been established that babies born to mothers who smoked are more likely to be obese. However, researchers at the University of Alberta believe they're closer to understanding why that ...
- Novo Nordisk ties up with Metaphore to develop new obesity drugson May 9, 2024 at 5:55 am
Novo Nordisk signed a research tie-up with U.S. biotech firm Metaphore on Thursday to develop next-generation obesity drugs.
- Opinion: A year on Ozempic taught me we’re thinking about obesity all wrongon May 8, 2024 at 10:01 pm
This is happening because we are trapped in a set of old stories about what obesity is and the morally acceptable ways to overcome it. But the fact that so many of us are turning to the new ...
via Bing News